This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Top-Ranked Stocks With Rising P/E Worth Investing In
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Planet Fitness (PLNT), AlloVir (ALVR), Entergy (ETR), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).
Brown-Forman's (BF.B) Brands & Strategies Provide Growth Impetus
by Zacks Equity Research
Brown-Forman (BF.B) continues to benefit from its strong brand portfolio, premiumization efforts and aggressive brand investments.
Will Keurig's (KDP) Pricing & Innovation Efforts Revive Stock?
by Zacks Equity Research
Keurig (KDP) continues to struggle with pressures from input cost inflation, higher marketing costs and supply-chain disruptions. Its pricing efforts look commendable, which should aid performance.
PepsiCo (PEP) Rallies on Q2 Earnings Beat & Raised 2023 View
by Zacks Equity Research
PepsiCo's (PEP) Q2 results reflect continued gains from the momentum in its global beverage and convenient food businesses. The company raises its 2023 view.
Here's Why Diageo (DEO) Looks Well-Poised Despite Cost Headwinds
by Zacks Equity Research
Diageo (DEO) is positioned to gain from robust demand trends, premiumization efforts, a strong brand portfolio, pricing actions and productivity saving efforts amid escalating costs.
Zacks Industry Outlook Highlights Constellation Brands, Brown-Forman, Molson Coors, The Boston Beer and The Duckhorn Portfolio
by Zacks Equity Research
Constellation Brands, Brown-Forman, Molson Coors, The Boston Beer and The Duckhorn Portfolio are part of the Zacks Industry Outlook article.
5 Stocks to Watch as the Alcohol Industry Trends Turn Unfavorable
by Rajani Lohia
The Beverages - Alcohol industry has been in trouble lately due to elevated input and packaging costs, supply-chain disruptions, and higher marketing expenses. Players like STZ, BF.B, TAP, SAM and NAPA are likely to capitalize on persistent innovation, premiumization and digital endeavors.
Here's Why AB InBev (BUD) Can Make it Big Despite Cost Headwinds
by Zacks Equity Research
AB InBev's (BUD) rapid expansion of its digital platform, leveraging technology, such as B2B sales and other e-commerce platforms, including BEES and Z¿¿ Delivery, bodes well.
Diageo (DEO) Looks Well-Poised on Premiumization Initiatives
by Zacks Equity Research
Diageo (DEO) is witnessing favorable trends on strong demand, advantaged portfolio and favorable industry trends of premiumization amid inflation woes.
Implied Volatility Surging for Duckhorn Portfolio (NAPA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Duckhorn Portfolio (NAPA) stock based on the movements in the options market lately.
Bet on DuPont Analysis to Pick 5 Stocks for Stellar Returns
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap PDD Holdings Inc. (PDD), OpGen (OPGN), AGCO (AGCO), A10 Networks (ATEN) and The Duckhorn Portfolio (NAPA).
How Much Upside is Left in The Duckhorn Portfolio, Inc. (NAPA)? Wall Street Analysts Think 40.28%
by Zacks Equity Research
The consensus price target hints at a 40.3% upside potential for The Duckhorn Portfolio, Inc. (NAPA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The Duckhorn Portfolio, Inc. (NAPA) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
The Duckhorn Portfolio, Inc. (NAPA) delivered earnings and revenue surprises of 33.33% and 1.70%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
AB InBev (BUD) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
AB InBev (BUD) Q1 results reflect gains from robust revenue per hectoliter (hl) growth, pricing actions and revenue management initiatives.
FEMSA's (FMX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
FEMSA's (FMX) first-quarter results reflect revenue growth across most regions. However, margin contractions at Proximity, Health and Envoy Solutions divisions affect operating margin.
Boston Beer (SAM) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Boston Beer's (SAM) Q1 results reflect the impacts of continued softness in the hard seltzer category. Declines in shipments and depletions, along with higher costs, hurt the results.
PepsiCo (PEP) Q1 Earnings & Revenues Beat Estimates, Stock Up
by Zacks Equity Research
PepsiCo's (PEP) Q1 results reflect gains from its diversified portfolio, modernized supply chain, digital capabilities, flexible go-to-market distribution systems and robust consumer demand trends.
Zacks Industry Outlook Highlights AnheuserBusch InBev, Constellation Brands, Brown-Forman, Molson Coors and The Duckhorn Portfolio
by Zacks Equity Research
AnheuserBusch InBev, Constellation Brands, Brown-Forman, Molson Coors and The Duckhorn Portfolio are part of the Zacks Industry Outlook article.
5 Stocks Poised to Benefit From Favorable Alcohol Industry Trends
by Rajani Lohia
The Beverages - Alcohol industry looks poised for growth on favorable demand trends, innovation, diversification, premiumization and digital growth amid elevated input and packaging costs. Players like BUD, STZ, BF.B, TAP and NAPA will likely capitalize.
Here's Why Investors Should Hold Brown-Forman (BF.B) Stock
by Zacks Equity Research
Solid demand for its brands, acquisitions, portfolio premiumization, product innovation and strategic relationships position Brown-Forman (BF.B) for growth amid cost headwinds.
Constellation Brands (STZ) Q4 Earnings Beat, Sales Miss
by Zacks Equity Research
Constellation Brands' (STZ) Q4 results reflect sales declines across the beer, and wine and spirits businesses, as well as increased costs.
Wall Street Analysts See a 26.58% Upside in The Duckhorn Portfolio, Inc. (NAPA): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in The Duckhorn Portfolio, Inc. (NAPA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
KNBWY vs. NAPA: Which Stock Is the Better Value Option?
Wall Street Analysts Think The Duckhorn Portfolio, Inc. (NAPA) Could Surge 28.46%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for The Duckhorn Portfolio, Inc. (NAPA) points to a 28.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Company News for Mar 10, 2023
by Zacks Equity Research
Companies in The News Are: FCEL,MEI,KRO,NAPA